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Introduction
Measurement of the 24-h excretion of urine free cortisol is a direct and reliable index of cortisol excretion re£ecting an integrated measure of serum free cortisol concentrations which is therefore useful in the investigation of Cushing's syndrome (CS). 1 Most laboratories routinely use automated immunoassay platforms and apply the procedure used for plasma to the analysis of urine. Due to interferences from steroid and cortisol metabolites present in urine, the results obtained on urine samples, depending on the method used, are sometimes double those obtained by more speci¢c methods such as high-performance liquid chromatography (HPLC). 2 Therefore, we recommend and from this point forward use the term urine free corticoids (UFC) as a more appropriate description of results obtained by automated immunoassay platforms.
However, automated immunoassay platforms have several advantages: they are relatively cheap and easy to use, have a rapid turn-around time and relatively good analytical precision. 1 Although HPLC has excellent speci¢city, it is labour intensive, requires specialized equipment and laboratory expertise, and the turn-around time is longer than for immunoassay analysers.
In this study, we describe a HPLC method modi¢ed from previous methods 3, 4 which speci¢cally isolates cortisol, as well as extends the number of corticosteroids which could be resolved in a single HPLC run. More importantly, by using our modi¢ed HPLC method as a urine free cortisol reference method, we were able to compare the outcomes suggested by the analytical results obtained by each assay to the ¢nal clinical diagnosis in a cohort of patients investigated for suspected CS.
Methods

Urine free cortisol by immunoassay
Immunoassay UFC measurements were obtained on the Immulite:2000 (Diagnostics Product Corporation, Los Angeles CA, USA) which is an immunochemiluminomeric assay using an alkaline phosphatase labelled conjugate with adamantyl dioxetane as the substrate. Urines were analysed directly on the Immulite:2000 without prior solvent extraction to obtain the UFC. The between-run coe⁄cient of variation for UFC at a mean concentration of 870 nmol/L was 5.4%.
The Immulite UFC reference interval was determined in-house on apparently healthy individuals who were not on exogenous corticosteroid therapy, UFC results ranged from 124 to 919 nmol/day with a mean7standard deviation of 4347220 nmol/day, and we adopted a UFC reference range of o900 nmol/day based on the upper 95th percentile.
Urine free cortisol by HPLC
Extraction procedure
Urine samples were centrifuged prior to solid-phase extraction of steroids using Waters Oasis HLB columns (Waters, Milford, MA, 3 cc, 60 mg) pre-activated with methanol and deionized water. A 1.95 mL aliquot of urine was mixed with 50 mL of 19.33 mmol/L 6 amethylprednisolone as an internal standard solution. A set of six calibration standards each containing the following ¢ve steroids was prepared by weighing pure crystalline steroid and preparing solutions covering the following concentration ranges: cortisone 26--809 nmol/L; cortisol 24--760 nmol/L, 11-deoxycortisol 25--798 nmol/L, dexamethasone, 16--512 nmol/L and prednisolone 17--548 nmol/L. Each of the standard steroids gave a linear peak area response over six dilutions covering the above ranges.
The urine samples spiked with internal standard, standards, controls and blanks (0.5 mL of methanol) were loaded onto the activated solid-phase extraction columns. The columns were washed with deionized water, sodium hydroxide, solutions of water and methanol (5% methanol and 95% water), water and acetone (20% acetone and 80% water). Steroids were eluted with 2 mL ethylacetate, which was then evaporated to dryness at 401C under a stream of nitrogen. Following reconstitution with 100 mL of mobile phase, 60 mL samples were injected into the HPLC system.
HPLC conditions
The HPLC system comprised a 717 WISP autosampler, 600E solvent delivery system and a 996 photodiode array detector (Waters, Milford, MA). Chromatography was performed using a Waters Nova-Pak 4 mm, 3.9 Â 300 mm C18 reverse phase column thermostated at 301C. A Hypersil ODS C18, 5 mm, 4.6 Â7.5 mm (Alltech) guard column was used as a pre-column. The mobile phase consisted of HPLC grade tetrahydrofuran, methanol and deionized water in the proportion of 14:3:73 by volume freshly prepared for each run and pumped at a £ow rate of 0.2 mL/min. The mobile phase was degassed by helium sparging at 50 mL/min for 30 min before use, and then at 20 mL/min before introducing into the HPLC system. The mobile phase was run isocratically at a £ow rate of 0.2 mL/min. Cortisol and other metabolites were separated over a total run time of 85 min. Waters Millennium software version 3.20 was used for data management and processing.
Between-run coe⁄cients of variation (CV) at mean urine free cortisol concentrations of 19 and 136 nmol/L were 13% and 8%, respectively and the detection limit for cortisol was 7.5 nmol/L.
Subjects Healthy subjects
The reference population for urine free cortisol analysis by HPLC comprised 24-h urine samples from 82 apparently healthy individuals,72 women and 10 men. These subjects were not on exogenous corticosteroid therapy and did not have any hypothalamic-pituitaryadrenal disorder.
Patients with an elevated immunoassay UFC
This is an observational, retrospective, cross-sectional study of the 39 patients who had samples referred to the PathWest Clinical Biochemistry Laboratory based at a tertiary hospital, the Sir Charles Gairdner Hospital, Western Australia, between 2000 and 2004. All the testing described was instituted as part of the regular diagnostic work-up for suspected CS.
Patients were initially seen either by a consultant endocrinologist or general physician who requested UFC as an initial investigation for suspected CS. Samples of 24-h urines were collected for UFC analysis by Immulite:2000. Patients who returned a UFC result elevated above our reference range of 900 nmol/day were referred to a chemical pathologist/endocrinologist (EML) for possible further investigation. Where a patient's presentation was either felt to be clinically suspicious of CS or where exclusion of the diagnosis was required, further investigations designed to diagnose CS were conducted. A total of 39 patients were further Ann Clin Biochem 2006; 43: 402-407 investigated for possible CS, including urine free cortisol analysis by our modi¢ed HPLC method.
Patients with confirmed Cushing's Syndrome
Of the 39 patients described above who returned a UFC result elevated above our reference range of 900 nmol/ day, a sub-set of 22 were shown to have CS. The characteristics of these patients with surgically proven CS are shown in Table 1 . They were considered cured by the criteria of clinical remission and normalization of biochemistry as determined by the attending endocrinologists.
Results
Urine free cortisol by HPLC
Five steroid compounds were used to obtain peak area calibration responses: cortisone, cortisol, 11-deoxycor-tisol, dexamethasone, prednisolone. By using an internal standard, 6a-methylprednisolone, we were able to control for possible losses of steroids throughout the procedure, including solid phase extraction, elution and HPLC separation.
To assess the e⁄cacy of HPLC resolution the following seven additional steroids were used: aldosterone, prednisone, corticosterone, 20b-dihydrocortisone, 20a-dihydrocortisone, 20b-dihydrocortisone, and 11deoxycorticosterone. The resolution achieved for all these steroid compounds is shown in Figure 1a with retention times given relative to that of the 6a-methylprednisolone internal standard. Good resolution was achieved for the following important synthetic and natural steroids: prednisone, cortisone, prednisolone, cortisol, corticosterone and dexamethasone. Typical chromatograms of urine samples from a healthy individual are shown in Figure1b and for a patient with CS in Figure 1c .
Urine free cortisol results for 24-h urine samples from 82 healthy subjects ranged from 19--172 nmol/ day, the median and interquartile ranges were 55 and 41--79 nmol/day, respectively. We adopted a urine free cortisol reference range of o170 nmol/day based on the observed range. Table 1 displays the characteristics of the 22 patients with surgically proven CS, together with HPLC and Immulite UFC data and relevant reference ranges obtained on baseline 24-h urine samples.
Patients with confirmed Cushing's Syndrome
Of the 22 patients,15 (68%) had pituitary-dependent CS. Four patients (18%) had ACTH-independent adrenal tumours with adrenal adenoma con¢rmed on histopathology and resolution of hypercortisolism after unilateral adrenalectomy. Two patients had an ectopic source of ACTH (9%), including one patient where the ACTH was secreted by a hepatoblastoma, which was successfully surgically resected. The remaining patients had adrenal carcinoma. All the 22 patients with a diagnosis of CS had elevated baseline UFC and urine free cortisol results falling in the irrespective reference intervals. A quantitative HPLC urine free cortisol result could not be obtained in one patient (see Table 1 ) due to interference.
Excluding Cushing's Syndrome
Of the 39 patients with a high clinical suspicion of CS and an elevated Immulite UFC, CS was excluded in 17 patients as described below.
Twelve patients had a urine free cortisol result within the reference range by the speci¢c HPLC method. In these patients, CS was excluded by a combination of the normal HPLC result and at least one of the following: a negative clinical evaluation, and/or an adequate dexamethasone suppression. The remaining ¢ve patients had elevations in both the immunoassay UFC and HPLC urine free cortisol results and the criteria for the exclusion of CS is described for each case in Table 2 . In summary, two patients had adequate dexamethasone suppression, one was shown by urine creatinine estimation to have overcollected the 24-h urine sample, one had a normal subsequent UFC result and the remaining patient was considered to show stress-related increases for both UFC and urine free cortisol estimations.
Thus an initial elevated immunoassay UFC result was considered false positive in 17 and true positive in 22 patients, giving a positive predictive value of 56%. Given there were ¢ve patients with a false positive HPLC urine free cortisol result and 22 true positives, the positive predictive value for the HPLC assay was 81%.
Discussion
This is the ¢rst study comparing UFC measured on a commonly used automated immunoassay analyser with a speci¢c HPLC method.We con¢rm that immunoassay grossly overestimates urine cortisol; however, for our cohort of 39 patients who had a high index of clinical suspicion for CS, the positive predictive value of an elevated baseline UFC proved to be 56%. The study design did not consider the question of CS patients missed due to a normal immunoassay UFC result, however data on the sensitivity of UFC has been published. In their review of the role of the laboratory in the diagnosis of CS, Perry and Grossman 1 quote a UFC sensitivity of 95%. Immunoassay platforms are widely used in most medium to large clinical laboratories and UFC analysis can be relatively simply performed by any laboratory o¡ering plasma cortisol analysis. Despite its failings, our results suggest analysis of 24 h urine for UFC by immunoassay serves as a valid initial investigation for CS.
If a speci¢c HPLC method is available, as in our laboratory, we suggest the role of HPLC is to further investigate elevated immunoassay UFC results to assist in the elimination of false positive immunoassay results. In these circumstances our study found the application of the HPLC method improved the positive predictive value of an elevated result to 81%.
Immunoassay-based UFC methods have progressed from competitive binding, 5, 6 in-house and commercial radioimmunoassays 6 to the widely used automated non-isotopic immunoassays. However, the lack of speci-¢city of cortisol determinations in human urine remains a continuing and unresolved problem. 2, 6 The reference method for cortisol measurements is gas chromatography with isotope dilution mass spectrophotometry, an expensive and technically demanding method. 7 As this level of technology is not readily available, HPLC may be considered a valid secondary reference method, providing a relatively speci¢c estimation of urine free cortisol.
The urine free cortisol HPLC method described has been modi¢ed and improved from previously published techniques. 3, 4 By replacing traditional liquid-phase extraction of urinary cortisol with solid-phase extraction, we have improved chromatographic resolution and eight corticosteroid compounds can now be separated in a single HPLC run compared to the six published previously. 4 Nevertheless, it is acknowledged that HPLC analysis requires specialized equipment as well as speci¢c technical expertise.
The urine free cortisol reference interval for our HPLC method is o170 nmol/day. Despite the predominance of females (72/82) in the reference population, our data are similar to the reference ranges of 30--145 nmol/day obtained on 28 subjects by Turpeinen et al. 8 and 22--152 nmol/day on 101 subjects by Lin et al. 9 Although cortisol production apparently does not di¡er between sexes, 10 the few studies which explored gender di¡erences in urine free cortisol measurements have obtained con£icting results. Two studies reported that urine free cortisol measurements by radio immunoassay were often higher in men than in women, 11, 12 but one study using gas chromatography-mass spectrometry found much higher urine free cortisol values in women than in men. 13 Automated immunoassays are widely used for routine analysis of serum and urine cortisol given the rapid turn-around time. However, urine is a more complex matrix than serum as far as cortisol metabolites are concerned and many potentially interfering metabolites remain unidenti¢ed. Moreover, few of these substances have been tested by the commercial manufacturers for cross-reactivity in UFC measurements. 5, 6 In addition, immunoassays are susceptible to interferences from commonly prescribed exogenous synthetic corticosteroids such as prednisolone.
The commonly used practice of liquid/liquid extraction of urine with organic solvents such as ethyl acetate prior to immunoassay for UFC is not only time consuming but also introduces additional variability. This has been documented in a study comparing extracted and unextracted immunoassay UFC measurements to radio immunoassay, where the inter-assay coe⁄cient of variation for UFC increased to 12.1% after urine extraction, compared with 3.6% without extraction. 14 The signi¢cantly higher coe⁄cient of variation likely re£ects additional errors introduced by the extraction procedure in addition to a variable amount of cortisol removed from the urine during the process and we do not recommend prior organic solvent extraction prior to immunoassay UFC measurement.
The much higher reference intervals quoted for immunoassay UFC compared with HPLC urine free cortisol methods are largely attributed to the crossreactivity of interfering cortisol metabolites. Although it is often assumed that measurement of metabolites is not important, Kikuchi et al. 15 found that patients with adrenal dependent CS had elevated excretions of 11-deoxycortisol, 18-hydroxycortisol and cortisone metabolites as well as cortisol.
Urine free cortisol is useful in the investigation of CS as it re£ects the integrated cortisol production rate. However, the question remains whether an accurate and speci¢c urine cortisol determination, such as that obtained by HPLC, necessarily improves the diagnosis of CS. As cortisol is clearly not the only compound measured using immunoassay analysers, such determinations should be reported as UFC rather than urinary free cortisol.
In conclusion, we report that UFC analysis using an immunoassay analyser provides results, which serve as valid simple initial test in the investigation of CS. The fact that the analyser cortisol measurements also included cortisol metabolites was not an impediment, provided the appropriate reference range was adopted.
